Cited by 319Opioid Use Disorder TreatmentPain Management and Opioid UseMusculoskeletal pain and rehabilitation

Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review

Frank, Joseph W., Lovejoy, Travis I., Becker, William C., Morasco, Benjamin J., Koenig, Christopher J., Hoffecker, Lilian, Dischinger, Hannah R., Dobscha, Steven K. +1 more·2017·Annals of Internal Medicine

Abstract

BACKGROUND: Expert guidelines recommend reducing or discontinuing long-term opioid therapy (LTOT) when risks outweigh benefits, but evidence on the effect of dose reduction on patient outcomes has not been systematically reviewed. PURPOSE: To synthesize studies of the effectiveness of strategies to reduce or discontinue LTOT and patient outcomes after dose reduction among adults prescribed LTOT for chronic pain. DATA SOURCES: MEDLINE, EMBASE, PsycINFO, CINAHL, and the Cochrane Library from inception through April 2017; reference lists; and expert contacts. STUDY SELECTION: Original research published in English that addressed dose reduction or discontinuation of LTOT for chronic pain. DATA EXTRACTION: Two independent reviewers extracted data and assessed study quality using the U.S. Preventive Services Task Force quality rating criteria. All authors assessed evidence quality using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Prespecified patient outcomes were pain severity, function, quality of life, opioid withdrawal symptoms, substance use, and adverse events. DATA SYNTHESIS: Sixty-seven studies (11 randomized trials and 56 observational studies) examining 8 intervention categories, including interdisciplinary pain programs, buprenorphine-assisted dose reduction, and behavioral interventions, were found. Study quality was good for 3 studies, fair for 13 studies, and poor for 51 studies. Many studies reported dose reduction, but rates of opioid discontinuation ranged widely across interventions and the overall quality of evidence was very low. Among 40 studies examining patient outcomes after dose reduction (very low overall quality of evidence), improvement was reported in pain severity (8 of 8 fair-quality studies), function (5 of 5 fair-quality studies), and quality of life (3 of 3 fair-quality studies). LIMITATION: Heterogeneous interventions and outcome measures; poor-quality studies with uncontrolled designs. CONCLUSION: Very low quality evidence suggests that several types of interventions may be effective to reduce or discontinue LTOT and that pain, function, and quality of life may improve with opioid dose reduction. PRIMARY FUNDING SOURCE: Veterans Health Administration. (PROSPERO: CRD42015020347).

Integrity signals

Registry

Crossref · 10.7326/m17-0598

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In patients prescribed long-term opioid therapy for pain, success rates are better - 20% to 91% depending on the intervention used, although some of these interventions involved switching patients to buprenorphine rather than opioid cessation per se.

    “In patients prescribed long-term opioid therapy for pain, success rates are better – 20% to 91% depending on the intervention used (although some of these interventions involved switching patients to buprenorphine rather than opioid cessation per se). 44”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, C. J., Hoffecker, L., Dischinger, H. R., Dobscha, S. K., & Krebs, E. E.
Affiliations
University of Minnesota (US)
Venue
Annals of Internal Medicine
Published
2017-08-01
Volume
167
Issue
3
Pages
181-191
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2736543687
Cited by
318
References
99
Citations by year
2026: 16 · 2025: 22 · 2024: 25 · 2023: 29 · 2022: 43 · 2021: 45 · 2020: 53 · 2019: 33 · 2018: 41 · 2017: 10
FWCI
6.09
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Department of Veterans Affairs (IK2 HX001516, IK2 HX001914)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Pharmacology › Musculoskeletal pain and rehabilitation
Keywords
long-term opioid therapy, opioid dose reduction, opioid discontinuation, chronic pain, pain intensity, functional status, quality of life, opioid withdrawal symptoms, substance use, adverse events, behavioral interventions
MeSH terms
Analgesics, Opioid, Drug Administration Schedule, Humans, Quality of Life, Severity of Illness Index, Substance Withdrawal Syndrome, Treatment Outcome, Withholding Treatment, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review